Nissay Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.7M | Buy |
57,324
+1,516
| +3% | +$419K | 0.05% | 217 |
|
|
2026
Q1 | $16.5M | Sell |
55,808
-857
| -2% | -$255K | 0.09% | 160 |
|
|
2025
Q4 | $15.5M | Buy |
56,665
+2,071
| +4% | +$563K | 0.08% | 165 |
|
|
2025
Q3 | $14.8M | Sell |
54,594
-3,959
| -7% | -$1.08M | 0.08% | 166 |
|
|
2025
Q2 | $16.1M | Buy |
58,553
+9,856
| +20% | +$2.68M | 0.09% | 156 |
|
|
2025
Q1 | $12.9M | Buy |
48,697
+494
| +1% | +$122K | 0.08% | 172 |
|
|
2024
Q4 | $11.3M | Sell |
48,203
-548
| -1% | -$126K | 0.07% | 190 |
|
|
2024
Q3 | $10.8M | Buy |
48,751
+1,612
| +3% | +$334K | 0.07% | 192 |
|
|
2024
Q2 | $9.27M | Buy |
47,139
+600
| +1% | +$124K | 0.06% | 196 |
|
|
2024
Q1 | $10M | Buy |
46,539
+791
| +2% | +$166K | 0.07% | 186 |
|
|
2023
Q4 | $9.63M | Buy |
45,748
+1,534
| +3% | +$327K | 0.08% | 160 |
|
|
2023
Q3 | $8.85M | Buy |
44,214
+2,025
| +5% | +$403K | 0.08% | 157 |
|
|
2023
Q2 | $7.82M | Buy |
42,189
+2,310
| +6% | +$427K | 0.07% | 175 |
|
|
2023
Q1 | $7.64M | Sell |
39,879
-1,428
| -3% | -$258K | 0.07% | 169 |
|
|
2022
Q4 | $6.95M | Buy |
41,307
+42
| +0.1% | +$7.3K | 0.07% | 178 |
|
|
2022
Q3 | $7.31M | Buy |
41,265
+1,524
| +4% | +$301K | 0.08% | 151 |
|
|
2022
Q2 | $8.13M | Buy |
39,741
+239
| +0.6% | +$50.7K | 0.08% | 143 |
|
|
2022
Q1 | $9.4M | Buy |
39,502
+934
| +2% | +$219K | 0.08% | 145 |
|
|
2021
Q4 | $8.81M | Buy |
38,568
+1,172
| +3% | +$258K | 0.07% | 174 |
|
|
2021
Q3 | $7.23M | Buy |
37,396
+1,500
| +4% | +$304K | 0.06% | 183 |
|
|
2021
Q2 | $7.63M | Buy |
35,896
+1,840
| +5% | +$388K | 0.07% | 172 |
|
|
2021
Q1 | $6.96M | Sell |
34,056
-20,550
| -38% | -$4.05M | 0.07% | 171 |
|
|
2020
Q4 | $9.94M | Sell |
54,606
-10,265
| -16% | -$1.75M | 0.15% | 123 |
|
|
2020
Q3 | $10.9M | Sell |
64,871
-11,587
| -15% | -$1.95M | 0.18% | 107 |
|
|
2020
Q2 | $12.4M | Sell |
76,458
-23,513
| -24% | -$4.21M | 0.24% | 100 |
|
|
2020
Q1 | $17.3M | Buy |
99,971
+51,394
| +106% | +$10.2M | 0.44% | 62 |
|
|
2019
Q4 | $9.75M | Sell |
48,577
-5,633
| -10% | -$1.16M | 0.22% | 110 |
|
|
2019
Q3 | $11.5M | Sell |
54,210
-13,599
| -20% | -$2.84M | 0.28% | 90 |
|
|
2019
Q2 | $13.2M | Buy |
67,809
+9,942
| +17% | +$1.83M | 0.33% | 79 |
|
|
2019
Q1 | $9.52M | Sell |
57,867
-1,456
| -2% | -$257K | 0.25% | 96 |
|
|
2018
Q4 | $11.2M | Buy |
59,323
+1,022
| +2% | +$189K | 0.34% | 73 |
|
|
2018
Q3 | $9.92M | Buy |
58,301
+10,577
| +22% | +$1.78M | 0.27% | 87 |
|
|
2018
Q2 | $7.82M | Buy |
47,724
+8,034
| +20% | +$1.31M | 0.23% | 108 |
|
|
2018
Q1 | $6.42M | Sell |
39,690
-922
| -2% | -$147K | 0.2% | 124 |
|
|
2017
Q4 | $5.93M | Buy |
+40,612
| New | +$5.78M | 0.18% | 141 |
|
Other funds holding CME
Nissay Asset Management's CME Position: Q2 2026 in Review
Nissay Asset Management increased its CME Group (CME) stake by 2.7% in Q2 2026, buying an estimated $419K and bringing the position to 57,324 shares worth $12.7M. The position accounts for 0.05% of the portfolio, ranked #217.
Nissay Asset Management first reported a position in CME in Q4 2017 and has held it in 35 quarters since. The position peaked at $17.3M in Q1 2020. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Nissay Asset Management held 57,324 shares of CME Group worth $12.7M as of Q2 2026.
- Nissay Asset Management bought 1,516 CME Group shares in Q2 2026, an estimated $419K.
- CME Group made up 0.05% of Nissay Asset Management's portfolio in Q2 2026, its #217 holding.
- Nissay Asset Management first reported a position in CME Group in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's CME Group position peaked at $17.3M in Q1 2020.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.